These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26933467)

  • 1. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers.
    Walters J; Cazzell S; Pham H; Vayser D; Reyzelman A
    Eplasty; 2016; 16():e10. PubMed ID: 26933467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
    Cazzell S
    Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DermACELL: Human Acellular Dermal Matrix Allograft A Case Report.
    Cole WE
    J Am Podiatr Med Assoc; 2016 Mar; 106(2):133-7. PubMed ID: 27031550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers.
    Robb GL; Gurtner GC
    Eplasty; 2016; 16():e27. PubMed ID: 27648117
    [No Abstract]   [Full Text] [Related]  

  • 6. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix.
    Cazzell S; Moyer PM; Samsell B; Dorsch K; McLean J; Moore MA
    Adv Skin Wound Care; 2019 Sep; 32(9):409-415. PubMed ID: 31361269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis on the clinical effects of allogenic acellular dermal matrix treatment for diabetic foot ulcer].
    Xue CL; Hu ZC; Yang ZX; Li XJ
    Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):725-729. PubMed ID: 28043296
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of severe burn with DermACELL(®), an acellular dermal matrix.
    Chen SG; Tzeng YS; Wang CH
    Int J Burns Trauma; 2012; 2(2):105-9. PubMed ID: 23071908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
    Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
    Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
    Reyzelman AM; Bazarov I
    J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis.
    Guo X; Mu D; Gao F
    Int J Surg; 2017 Apr; 40():1-7. PubMed ID: 28232031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.
    Lantis JC; Snyder R; Reyzelman AM; Van Gils CC; Sigal F; Vayser D; Caporusso JM; Cazzell S; Lavery LA;
    J Wound Care; 2021 Jul; 30(Sup7):S18-S27. PubMed ID: 34256588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities.
    Williams ML; Holewinski JE
    J Wound Care; 2015 Jun; 24(6):261-2, 264-7. PubMed ID: 26075374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximal Tibial Cortex Transverse Distraction Facilitating Healing and Limb Salvage in Severe and Recalcitrant Diabetic Foot Ulcers.
    Chen Y; Kuang X; Zhou J; Zhen P; Zeng Z; Lin Z; Gao W; He L; Ding Y; Liu G; Qiu S; Qin A; Lu W; Lao S; Zhao J; Hua Q
    Clin Orthop Relat Res; 2020 Apr; 478(4):836-851. PubMed ID: 31794478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study.
    Kavros SJ; Dutra T; Gonzalez-Cruz R; Liden B; Marcus B; McGuire J; Nazario-Guirau L
    Adv Skin Wound Care; 2014 Aug; 27(8):356-62. PubMed ID: 25033310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based care for chronic wound management: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(18):1-24. PubMed ID: 23074522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.
    Brigido SA
    Int Wound J; 2006 Sep; 3(3):181-7. PubMed ID: 16984575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.